AXITINIB for Thyroid cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where AXITINIB was used for Thyroid cancer.
Most Reported Side Effects for AXITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,222 | 14.0% | 2,212 | 148 |
| Diarrhoea | 2,187 | 13.8% | 121 | 539 |
| Fatigue | 1,816 | 11.5% | 102 | 340 |
| Neoplasm progression | 1,315 | 8.3% | 354 | 236 |
| Hypertension | 1,146 | 7.2% | 78 | 320 |
| Off label use | 1,075 | 6.8% | 338 | 178 |
| Nausea | 955 | 6.0% | 74 | 225 |
| Decreased appetite | 920 | 5.8% | 123 | 283 |
| Dysphonia | 871 | 5.5% | 55 | 184 |
| Disease progression | 768 | 4.8% | 242 | 171 |
| Blood pressure increased | 756 | 4.8% | 45 | 166 |
| Weight decreased | 695 | 4.4% | 61 | 184 |
| Asthenia | 629 | 4.0% | 81 | 232 |
| Stomatitis | 514 | 3.2% | 44 | 107 |
| Headache | 504 | 3.2% | 19 | 116 |
Other Indications for AXITINIB
Renal cancer (3,422)
Renal cell carcinoma (2,447)
Metastatic renal cell carcinoma (1,612)
Clear cell renal cell carcinoma (480)
Renal cancer metastatic (456)
Neoplasm malignant (412)
Product used for unknown indication (223)
Renal cell carcinoma stage iv (176)
Renal cancer stage iv (96)
Metastases to lung (82)
Other Drugs Used for Thyroid cancer
LENVATINIB (2,668)
CABOZANTINIB S-MALATE (1,615)
VANDETANIB (591)
DABRAFENIB (583)
TRAMETINIB DIMETHYL SULFOXIDE (482)
SORAFENIB (399)
LEVOTHYROXINE (299)
PAZOPANIB (264)
PRALSETINIB (199)
CABOZANTINIB (125)